- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1534-3189
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Role of Biomarkers in Prediction of Cardiotoxicity During Cancer Treatment ; volume:20 ; number:7 ; day:19 ; month:6 ; year:2018 ; pages:1-14 ; date:7.2018
Current treatment options in cardiovascular medicine ; 20, Heft 7 (19.6.2018), 1-14, 7.2018
- Creator
-
Tan, Li-Ling
- Contributor
-
Lyon, Alexander R.
SpringerLink (Online service)
- DOI
-
10.1007/s11936-018-0641-z
- URN
-
urn:nbn:de:101:1-2018092418523356928530
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:40 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Tan, Li-Ling
- Lyon, Alexander R.
- SpringerLink (Online service)
Other Objects (12)
Left ventricular ejection fraction and cardiac biomarkers for dynamic prediction of cardiotoxicity in early breast cancer
Cardiotoxicity—current recommendations of prevention and treatment
Treatment of local anaesthetic induced cardiotoxicity with lipid infusion
Precision Treatment of Anthracycline-Induced Cardiotoxicity: An Updated Review
Prediction of doxorubicin cardiotoxicity by early detection of subclinical right ventricular dysfunction
Artificial intelligence-enabled prediction of chemotherapy-induced cardiotoxicity from baseline electrocardiograms
Cardiotoxicity after cancer treatment: a process map of the patient treatment journey
Mechanisms of trastuzumab induced cardiotoxicity – is exercise a potential treatment?
Anthracycline induced cardiotoxicity: biomarkers and “Omics” technology in the era of patient specific care
Prediction of epileptogenesis by multimodal biomarkers
Metabolic Aspects of Anthracycline Cardiotoxicity
Role of metabolites of cyclophosphamide in cardiotoxicity
Left ventricular ejection fraction and cardiac biomarkers for dynamic prediction of cardiotoxicity in early breast cancer
Cardiotoxicity—current recommendations of prevention and treatment
Treatment of local anaesthetic induced cardiotoxicity with lipid infusion
Precision Treatment of Anthracycline-Induced Cardiotoxicity: An Updated Review
Prediction of doxorubicin cardiotoxicity by early detection of subclinical right ventricular dysfunction
Artificial intelligence-enabled prediction of chemotherapy-induced cardiotoxicity from baseline electrocardiograms
Cardiotoxicity after cancer treatment: a process map of the patient treatment journey
Mechanisms of trastuzumab induced cardiotoxicity – is exercise a potential treatment?
Anthracycline induced cardiotoxicity: biomarkers and “Omics” technology in the era of patient specific care
Prediction of epileptogenesis by multimodal biomarkers
Metabolic Aspects of Anthracycline Cardiotoxicity
Role of metabolites of cyclophosphamide in cardiotoxicity
Left ventricular ejection fraction and cardiac biomarkers for dynamic prediction of cardiotoxicity in early breast cancer
Cardiotoxicity—current recommendations of prevention and treatment
Treatment of local anaesthetic induced cardiotoxicity with lipid infusion
Precision Treatment of Anthracycline-Induced Cardiotoxicity: An Updated Review
Prediction of doxorubicin cardiotoxicity by early detection of subclinical right ventricular dysfunction
Artificial intelligence-enabled prediction of chemotherapy-induced cardiotoxicity from baseline electrocardiograms
Cardiotoxicity after cancer treatment: a process map of the patient treatment journey
Mechanisms of trastuzumab induced cardiotoxicity – is exercise a potential treatment?
Anthracycline induced cardiotoxicity: biomarkers and “Omics” technology in the era of patient specific care
Prediction of epileptogenesis by multimodal biomarkers
Metabolic Aspects of Anthracycline Cardiotoxicity